2023 Form 5500 filing — Denali Therapeutics 401(K) Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20240930104012NAL0010005248001) for Denali Therapeutics 401(K) Plan, reported by Denali Therapeutics Inc. under EIN 46-3872213 and plan number 001. It reports 424 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials).
- EFAST2 acknowledgement
- 20240930104012NAL0010005248001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Denali Therapeutics Inc.
- EIN
- 46-3872213
- Plan number
- 001
- Location
- South San Francisco, CA
- Participants
- 424
- Schedules available
- Schedule H
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $49,662,877
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $49,662,877
- Employer contributions
- $3,213,315
- Participant contributions
- $6,797,370
- Total income / additions
- $19,780,813
- Benefits paid
- $2,168,951
- Administrative expenses
- $1,079
- Total expenses
- $2,170,539
- Net increase / (decrease)
- $17,610,274
- Schedule source
- Schedule H